Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hearing Aids
FDA Approves Implant Device
November 12th, 2000
The U.S. Food and Drug Administration has approved a brain implant device that may restore some hearing for patients who became deaf after tumors were removed from auditory nerves. The device, called the Nucleus 24 Multichannel Auditory Brainstem Implant, or ABI, is approved for use in teenagers and adults with neurofibromatosis Type II, an inherited condition that affects about one American in 40,000. The ABI is the first hearing-assisting device approved for implanting in the brainstem. Another device, called the cochlear implant, is surgically implanted near the inner ear and is designed to help patients with a different type of hearing loss....
Source: Medical Letter on the CDC & FDA (2000-11-12)
|
